← Back to Clinical Trials
Recruiting NCT06720779

Virtual Rehabilitation Platform for Patients With Knee Prothesis

Trial Parameters

Condition Knee Arthropathy
Sponsor Trak Health Solutions S.L.
Study Type INTERVENTIONAL
Phase N/A
Enrollment 20
Sex ALL
Min Age 18 Years
Max Age 85 Years
Start Date 2024-06-05
Completion 2025-06-05
Interventions
TRAK physio knee prosthesis protocolKnee conventional rehabilitation program

Brief Summary

This clinical trial aims to evaluate the effectiveness and usability of the Trak Rehabilitation Platform in patients who have undergone knee replacement surgery. Its main questions are whether the Trak platform combined with conventional therapy helps patients achieve optimal functionality with fewer in-person sessions compared to conventional rehabilitation alone and whether the Trak platform improves adherence to treatment, independence in daily activities, and quality of life while reducing resource consumption. Researchers will compare the use of the Trak platform combined with conventional rehabilitation to standard rehabilitation practices to determine its impact on functional outcomes, patient and provider satisfaction, and resource efficiency. Participants will: * Use the Trak Platform as part of their personalized treatment plan. * Attend face-to-face rehabilitation sessions as prescribed. * Participate in assessments to measure functionality, adherence, independence, quality of life, and resource utilization.

Eligibility Criteria

Inclusion Criteria: * Patients aged \>18 and ≤85 years. * Patients who underwent surgery for the implantation of a knee prosthesis at the Knee Unit of the Cruces University Hospital. * Patients who require on-site rehabilitation at the Cruces university hospital rehabilitation service. * Patients who have signed the Informed Consent. Exclusion Criteria: * Patients with intellectual disability or cognitive impairment. * Patients with a history of knee infection. * Patients who cannot make use of mobile applications, cell phones, tablets, laptops or e- mail and who do not have the support of a family member or caregiver to provide support to make use of these technologies. * Patients who have not signed the Informed Consent.

Related Trials